Associate Director/Director, Business Development and Operations

About QED Therapeutics & BridgeBio Pharma

QED Therapeutics, an affiliate of BridgeBio Pharma, focuses on developing targeted treatments for FGFR-driven skeletal dysplasias, particularly Achondroplasia. Achondroplasia is the most common form of genetically-driven short stature, which causes potentially debilitating medical complications. With our experimental therapeutic candidate, infigratinib, we seek to provide an option to children living with Achondroplasia and their families.
 
Our business is inspired by our values:

• PUT PATIENTS FIRST
• LET SCIENCE SPEAK
• EVERY MINUTE COUNTS
• THINK INDEPENDENTLY
• BE RADICALLY TRANSPARENT

FGFR=fibroblast growth factor receptor.

BridgeBio is a biopharmaceutical company founded to discover, create, test, and deliver transformative medicines to treat patients who suffer from genetic diseases and cancers with clear genetic drivers. We bridge the gap between remarkable advancements in genetic science in academic institutions and the delivery of meaningful medicines to patients. Founded in 2015, the company has built a portfolio of 30+ drug development programs ranging from preclinical to late-stage development in multiple therapeutic areas including genetic dermatology, precision oncology, cardiology, endocrinology, neurology, pulmonology, and renal disease, with two approved drugs.

Our focus on scientific excellence and rapid execution aims to translate today’s discoveries into tomorrow’s medicines. We have U.S. offices in San Francisco, Palo Alto, Raleigh, and with small satellites in other parts of the country. We also have international offices in Montreal, Canada, and Zug, Switzerland, and are expanding across Europe.

To learn more about our story and company culture, visit us at https://www.qedtx.com/ | https://bridgebio.com 

Who You Are

The Business Development & Operations (BD & Ops) is a high-visibility strategic role that is focused on risk-trade off assessments in drug development decisions, with an ability to execute on business development transactions when necessary. This includes setting up strategic timelines, the scientific plan, business plan, strategy, NPV modeling, Gantt Charts, vendor relations, contract negotiations, execution and management. The Associate Director of BD&Ops reports to the Senior Director of Strategy and Operations at BridgeBio, and will specifically focus on the strategic, competitive intelligence and business development activities for the QED Therapeutics, the skeletal dysplasias affiliate within BridgeBio. The candidate must have demonstrated excellence at managing diverse stakeholders, many at a very senior level, and exquisite attention to detail. Given the intense focus on science within BridgeBio, the candidate must have a solid scientific background and knowledge of drug development process. 

Responsibilities

• Driving cross-functional alignment and harmonization of strategy with operational activities for the expansion area clinical program 
• Identifying and collaborating with functional experts as strategic partners to support the success of infigratinib 
• Owning competitive intelligence for achondroplasia and hypochondroplasia 
• Able to run a partnering process under some supervision (e.g. introductory calls with third parties, initial negotiations – verbal, in-person, emails) 
• Supporting the development of infigratinib and evaluating strategic investment  
• Performing other strategic analyses as needed by the Company 
• Set, prioritize and manage milestones & deliverables for team members in one or more subsidiary companies 
• Coordinate team meetings and delegate to technical experts in one or more subsidiary companies 
• Interpret, collate, and communicate critical data findings in a concise manner to senior management 
• Ability & desire to identify problems, locate the resources and find data-driven solutions independent of supervision 

No matter your role at BridgeBio, successful team members are:

• Patient Champions, who put patients first and uphold strict ethical standards
• Entrepreneurial Operators, who drive toward practical solutions and have an ownership mindset
• Truth Seekers, who are detailed, rational, and humble problem solvers
• Individuals Who Inspire Excellence in